Skip to main content
Log in

Preventable and Non-Preventable Adverse Drug Events in Hospitalized Patients

A Prospective Chart Review in the Netherlands

  • Original Research Article
  • Published:
Drug Safety Aims and scope Submit manuscript

Abstract

Background: Medication safety research and clinical pharmacy practice today is primarily focused on managing preventable adverse drug events (pADEs). Determinants of both pADEs and non-preventable adverse drug reactions (ADRs) have been identified. However, relatively little is known on the overlap between these determinants and the balance of preventable and non-preventable harm inpatients experience in modern computerized hospitals.

Objective: The aim of this study was to analyse the prevalence of pADEs and non-preventable ADRs as well as the determinants, including multimorbidity, of these ADEs, i.e. both pADEs and ADRs.

Methods: Adverse events experienced by patients admitted to two Dutch hospitals with functioning computerized physician order entry (CPOE) systems were prospectively identified through chart review. Adverse events were divided into pADEs (i.e. as a result of a medication error) and non-preventable ADRs. In both cases, a causal relationship between adverse events and patients’ drugs was established using the simplified Yale algorithm. Study data were collected anytime between April 2006 and May 2008 over a 5-month period at each hospital ward included in the study, beginning from 8 weeks after CPOE was implemented at the ward.

Results: pADEs and non-preventable ADRs were experienced by 349 (58%) patients, of whom 307 (88%) had non-preventable ADRs. Multimorbidity (adjusted odds ratio [ORadj] 1.90; 95% CI 1.44,2.50; ORadj 1.28; 95% CI 1.14, 1.45, respectively), length of stay (ORadj 1.13; 95% CI 1.06, 1.21; ORadj 1.11; 95% CI 1.07, 1.16, respectively), admission to the geriatric ward (ORadj 7.78; 95% CI 2.15, 28.13; ORadj 3.82; 95% CI 1.73, 8.45, respectively) and number of medication orders (ORadj 1.25; 95% CI 1.16,1.35; ORadj 1.13; 95% CI 1.06, 1.21, respectively) were statistically significantly associated with pADEs and ADRs. Admission to the gastroenterology/rheumatology ward (ORadj 0.22; 95% CI 0.06, 0.77; ORadj 0.40; 95% CI 0.24, 0.65, respectively) was inversely related to both pADEs and ADRs. Other determinants for ADRs only were female sex (ORadj 1.77; 95% CI 1.12, 2.80) and use of drugs affecting the nervous system (ORadj 1.83; 95% CI 1.09, 3.07). Age was a significant determinant for pADEs only (ORadj 1.07; 95% CI 1.03, 1.11).

Conclusions: In this study more than half of the patients admitted to the hospitals are harmed by drugs, of which most are non-serious, non-preventable ADRs (after the introduction of CPOE). Determinants of both pADEs and ADRs overlap to a large extent. Our results imply the need for signalling early potential adverse events that occur during the normal use of drugs in multimorbid patients or those in geriatric wards. Subsequent therapeutic interventions may improve the well-being of hospitalized patients to a greater extent than focusing on errors in the medication process only.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II
Fig. 1
Table III
Table IV
Table V

Similar content being viewed by others

References

  1. Kohn L, Corrigan J, Donaldson M, Committee on Quality of Health Care in America, Institute of Medicine. To err is human: building a safer health system. Washington, DC: National Academy Press, 1999

    Google Scholar 

  2. van Doormaal JE, van den Bemt PMLA, Mol PGM, et al. Medication errors: the impact of prescribing and transcribing errors on preventable harm in hospitalised patients. Qual Saf Health Care 2009; 18: 22–7

    Article  PubMed  Google Scholar 

  3. Ammenwerth E, Schnell-Inderst P, Machan C, et al. The effect of electronic prescribing on medication errors and adverse drug events: a systematic review. J Am Med Inform Assoc 2008; 15(5): 585–600

    Article  PubMed  Google Scholar 

  4. van Doormaal JE, van den Bemt PM, Zaal RJ, et al. The influence of computerized prescribing on medication errors and preventable adverse drug events: an interrupted time series study. J Am Med Inform Assoc 2009; 16: 816–25

    Article  PubMed  Google Scholar 

  5. Nebeker JR, Hoffman JM, Weir CR, et al. High rates of adverse drug events in a highly computerized hospital. Arch Intern Med 2005; 165(10): 1111–6

    Article  PubMed  Google Scholar 

  6. Eslami S, de Keizer NF, Abu-Hanna A. The impact of computerized physician medication order entry in hospitalized patients: a systematic review. Int J Med Inform 2008; 77(6): 365–76

    Article  PubMed  Google Scholar 

  7. Shamliyan TA, Duval S, Du J, et al. Just what the doctor ordered: review of the evidence of the impact of computerized physician order entry system on medication errors. Health Serv Res 2008; 43 (1 Pt 1): 32–53

    Article  PubMed  Google Scholar 

  8. Aronson JK, Ferner RE. Preventability of drug-related harms — part II: proposed criteria, based on frameworks that classify adverse drug reactions. Drug Saf 2010; 33(11): 995–1002

    Article  PubMed  Google Scholar 

  9. Rommers MK, Teepe-Twiss IM, Guchelaar HJ. Preventing adverse drug events in hospital practice: an overview. Pharmacoepidemiol Drug Saf 2007; 16(10): 1129–35

    Article  PubMed  Google Scholar 

  10. Krahenbuhl-Melcher A, Schlienger R, Lampert M, et al. Drug-related problems in hospitals: a review of the recent literature. Drug Saf 2007; 30(5): 379–407

    Article  PubMed  Google Scholar 

  11. Hoonhout LH, de Bruijne MC, Wagner C, et al. Nature, occurrence and consequences of medication-related adverse events during hospitalization: a retrospective chart review in the Netherlands. Drug Saf 2010; 33(10): 853–64

    Article  PubMed  Google Scholar 

  12. Jain V, Pitchumoni CS. Gastrointestinal side effects of prescription medications in the older adult. J Clin Gastro-enterol 2009; 43(2): 103–10

    Article  Google Scholar 

  13. Hurwitz N. Predisposing factors in adverse reactions to drugs. BMJ 1969; 1(5643): 536–9

    Article  PubMed  CAS  Google Scholar 

  14. Camargo AL, Cardoso Ferreira MB, Heineck I. Adverse drug reactions: a cohort study in internal medicine units at a university hospital. Eur J Clin Pharmacol 2006; 62(2): 143–9

    Article  PubMed  Google Scholar 

  15. van den Bemt PM, Egberts AC, Lenderink AW, et al. Risk factors for the development of adverse drug events in hospitalized patients. Pharm World Sci 2000; 22(2): 62–6

    Article  PubMed  Google Scholar 

  16. Onder G, Petrovic M, Tangiisuran B, et al. Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older: the GerontoNet ADR risk score. Arch Intern Med 2010; 170(13): 1142–8

    Article  PubMed  Google Scholar 

  17. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998; 279(15): 1200–5

    Article  PubMed  CAS  Google Scholar 

  18. Leendertse AJ, Egberts AC, Stoker LJ, et al. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med 2008; 168(17): 1890–6

    Article  PubMed  Google Scholar 

  19. Kuperman GJ, Bobb A, Payne TH, et al. Medication-related clinical decision support in computerized provider order entry systems: a review. J Am Med Inform Assoc 2007; 14(1): 29–40

    Article  PubMed  Google Scholar 

  20. WHO. International statistical classification of disease and related health problems, tenth revision (ICD-10). Geneva: WHO, 2002

    Google Scholar 

  21. WHO Collaborating Centre for Drug Statistics Methodology. ATC/DDD index 2011 [online]. Available from URL: http://www.whocc.no/atc_ddd_index/ [Accessed 2011 Mar 8]

  22. WHO Collaborating Centre for International Drug Monitoring. The WHO adverse reaction terminology: terminology for coding clinical information in relation to drug therapy [online]. Available from URL: http://www.umc-products.com/graphics/3149.pdf [Accessed 2011 Mar 8]

  23. van den Bemt PM, Egberts AC. Drug-related problems: definitions and classification. EJHP Practice 2007; 13: 62–4

    Google Scholar 

  24. National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP). NCC MERP index for categorizing medication errors [online]. Available from URL: http://www.nccmerp.org/pdf/indexColor2001-06-12.pdf [Accessed 2011 Mar 8]

  25. Kramer MS, Leventhal JM, Hutchinson TA, et al. An algorithm for the operational assessment of adverse drug reactions: background, description, and instructions for use. JAMA 1979; 242: 623–32

    Article  PubMed  CAS  Google Scholar 

  26. van Doormaal JE, Mol PG, van den Bemt PM, et al. Reliability of the assessment of preventable adverse drug events in daily clinical practice. Pharmacoepidemiol Drug Saf 2008; 17(7): 645–54

    Article  PubMed  Google Scholar 

  27. Schnipper JL, Kirwin JL, Cotugno MC, et al. Role of pharmacist counseling in preventing adverse drug events after hospitalization. Arch Intern Med 2006; 166(5): 565–71

    Article  PubMed  Google Scholar 

  28. Weir C, Hoffman J, Nebeker JR, et al. Nurse’s role in tracking adverse drug events: the impact of provider order entry. Nurs Adm Q 2005; 29(1): 39–44

    Article  PubMed  Google Scholar 

  29. Jha AK, Kuperman GJ, Teich JM, et al. Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report. J Am Med Inform Assoc 1998; 5(3): 305–14

    Article  PubMed  CAS  Google Scholar 

  30. Morimoto T, Gandhi TK, Seger AC, et al. Adverse drug events and medication errors: detection and classification methods. Qual Saf Health Care 2004; 13(4): 306–14

    Article  PubMed  CAS  Google Scholar 

  31. Bates DW, Leape LL, Petrycki S. Incidence and preventability of adverse drug events in hospitalized adults. J Gen Intern Med 1993; 8(6): 289–94

    Article  PubMed  CAS  Google Scholar 

  32. Field TS, Gurwitz JH, Avorn J, et al. Risk factors for adverse drug events among nursing home residents. Arch Intern Med 2001; 161(13): 1629–34

    Article  PubMed  CAS  Google Scholar 

  33. Field TS, Gurwitz JH, Harrold LR, et al. Risk factors for adverse drug events among older adults in the ambulatory setting. J Am Geriatr Soc 2004; 52(8): 1349–54

    Article  PubMed  Google Scholar 

  34. Leendertse AJ, de Koning FH, Goudswaard AN, et al. Preventing hospital admissions by reviewing medication (PHARM) in primary care: design of the cluster randomised, controlled, multi-centre PHARM-study. BMC Health Serv Res 2011; 11(1): 4

    Article  PubMed  Google Scholar 

  35. Rademaker M. Do women have more adverse drug reactions? Am J Clin Dermatol 2001; 2(6): 349–51

    Article  PubMed  CAS  Google Scholar 

  36. Anderson GD. Gender differences in pharmacological response. Int Rev Neurobiol 2008; 83: 1–10

    Article  PubMed  Google Scholar 

  37. Passarelli MC, Jacob-Filho W, Figueras A. Adverse drug reactions in an elderly hospitalised population: inappropriate prescription is a leading cause. Drugs Aging 2005; 22(9): 767–77

    Article  PubMed  Google Scholar 

  38. Egger T, Dormann H, Ahne G, et al. Identification of adverse drug reactions in geriatric inpatients using a computerised drug database. Drugs Aging 2003; 20(10): 769–76

    Article  PubMed  CAS  Google Scholar 

  39. Hoff TJ. How work context shapes physician approach to safety and error. Qual Manag Health Care 2008; 17(2): 140–53

    PubMed  Google Scholar 

Download references

Acknowledgements

We are grateful for the support of the Hospital Pharmacists of the UMCG and the Physician Order Entry and Medication Safety (POEMS) study research group, as well as the staff of the Department of Clinical Pharmacology for assessing causality of adverse events and helping with the analysis.

This work (file number 94504109) was funded in part by an unconditional grant from the Netherlands Organization for Health Research and Development (ZonMW). This agency played no role in the collection, analysis and interpretation of the data or in the decision to submit the manuscript for publication.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Peter G. M. Mol.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dequito, A.B., Mol, P.G.M., van Doormaal, J.E. et al. Preventable and Non-Preventable Adverse Drug Events in Hospitalized Patients. Drug-Safety 34, 1089–1100 (2011). https://doi.org/10.2165/11592030-000000000-00000

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/11592030-000000000-00000

Keywords

Navigation